The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Hims & Hers Health Inc’s stock clocked out at $26.56, down -6.77% from its previous closing price of $28.49. In other words, the price has decreased by -$6.77 from its previous closing price. On the day, 8.78 million shares were traded. HIMS stock price reached its highest trading level at $28.64 during the session, while it also had its lowest trading level at $26.38.
Ratios:
To gain a deeper understanding of HIMS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 36.16. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $42.
On August 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $24.Needham initiated its Buy rating on August 22, 2024, with a $24 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 26 ’24 when Okupe Oluyemi sold 4,213 shares for $29.98 per share. The transaction valued at 126,318 led to the insider holds 128,365 shares of the business.
Chi Michael sold 17,303 shares of HIMS for $483,965 on Dec 24 ’24. The Chief Commercial Officer now owns 193,601 shares after completing the transaction at $27.97 per share. On Dec 24 ’24, another insider, Chi Michael, who serves as the Officer of the company, bought 17,303 shares for $27.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 5802802176 and an Enterprise Value of 5560092160. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.44, and their Forward P/E ratio for the next fiscal year is 29.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.36 while its Price-to-Book (P/B) ratio in mrq is 13.15. Its current Enterprise Value per Revenue stands at 4.477 whereas that against EBITDA is 93.1.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $35.02, while it has fallen to a 52-week low of $8.09. The 50-Day Moving Average of the stock is 1.84%, while the 200-Day Moving Average is calculated to be 36.08%.
Shares Statistics:
It appears that HIMS traded 17.01M shares on average per day over the past three months and 12855570 shares per day over the past ten days. A total of 209.44M shares are outstanding, with a floating share count of 177.43M. Insiders hold about 18.79% of the company’s shares, while institutions hold 56.00% stake in the company. Shares short for HIMS as of 1734048000 were 42972111 with a Short Ratio of 2.53, compared to 1731628800 on 39517672. Therefore, it implies a Short% of Shares Outstanding of 42972111 and a Short% of Float of 22.41.
